RESOLUTE INTEGRITY RX
Report
- Report Number
- 9612164-2016-00984
- Event Type
- Malfunction
- Date Received
- September 21, 2016
- Date of Event
- April 24, 2015
- Report Date
- August 25, 2016
- Manufacturer
- MEDTRONIC IRELAND
- Product Code
- NIQ
- PMA / PMN Number
- P110013
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- EI
- Reporter Occupation
- PHYSICIAN
Narratives
(B)(4). JOURNAL: CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS ARTICLE TITLE: INCIDENCE AND MECHANISMS OF OF LONGITUDINAL STENT DEFORMATION ASSOCIATED WITH BIOMATRIX, RESOLUTE, ELEMENT, AND XIENCE STENTS DOI: 10.1002/CCD.25790. EVENT DATE IS DATE OF ARTICLE PUBLICATION. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
IT WAS REPORTED IN A JOURNAL ARTICLE THAT A CLINICAL STUDY WAS CARRIED OUT INVOLVING RESOLUTE INTEGRITY DRUG ELUTING STENTS AND OTHER NON MDT BRAND STENTS WITH A TOTAL OF 1800 PCI CASES. 450 PCI PROCEDURES USING RESOLUTE INTEGRITY DEVICES WERE WITHIN THE SCOPE OF THE STUDY. COLLECTIVELY THE LM, LAD, LCX, RCA AND VG VESSELS EXHIBITING CHRONIC TOTAL OCCLUSION, ISR, CALCIFICATION AND VESSEL TORTUOSITY WERE TREATED. DURING THE PROCEDURES LSD (LONGITUDINAL STENT DEFORMATION) OCCURRED IN 3 CASES. SECOND DEVICE LSD WAS REPORTED TO HAVE OCCURRED INVOLVING ENDEAVOR RESOLUTE. MAJOR COMPLICATIONS CAUSED BY LSD INCLUDING STENT THROMBOSIS, EMERGENCY CABG AND DEATH WERE REPORTED TO HAVE OCCURRED IN A PORTION OF STUDY PARTICIPANTS. MAJOR COMPLICATIONS CAUSED BY LSD INCLUDING STENT THROMBOSIS, EMERGENCY CORONARY ARTERY BYPASS SURGERY (CABG) AND DEATH HAVE BEEN REPORTED AS CASE REPORTS AND IN 7% AND 14% OF CASES IN TWO REPORTS FROM THE MAUDE COMPLICATIONS DATABASE. ALTHOUGH DESCRIBED WITH A VARIETY OF PLATFORMS, THESE REPORTS HAVE HIGHLIGHTED AN ASSOCIATION BETWEEN LSD AND THE PROMUS ELEMENT STENT WHICH HAS ALSO BEEN SHOWN TO BE LESS RESISTANT TO LONGITUDINAL COMPRESSION IN BENCH TESTING STUDIES LSD WAS DESCRIBED IN THE INITIAL PROCEDURE REPORT IN ONLY (B)(6) CASES. OF THE 16 UNRECOGNISED CASES, 13 CASES WERE NEVERTHELESS RE-EXPANDED AND 3 CASES WERE LEFT UNTREATED. IN ONE OF THE THREE UNTREATED CASES STENT THROMBOSIS LEADING TO CARDIOGENIC SHOCK OCCURRED AT THE SITE OF LSD 6 WEEKS POST PROCEDURE. LSD WAS SUCCESSFULLY RE-EXPANDED WITHOUT FURTHER SEQUELAE IN ALL REMAINING CASES. RE-EXPANSION WAS ACHIEVED BY POSTDILATION ALONE IN 12 CASES AND INVOLVED OVERLAPPING WITH A FURTHER STENT IN 9 CASES. HOWEVER, MARKED DIFFICULTY RE-ENTERING THE DEFORMED STENT WAS ENCOUNTERED IN 6 CASES OF SECONDARY DEVICE LSD ((B)(6) TREATED CASES) THAT REQUIRED THE USE OF MULTIPLE SMALL DIAMETER BALLOONS _1.5 MM TO RE-ENTER THE DEFORMED STENT. DIFFICULTY REENTERING THE STENT WAS NOT ENCOUNTERED IN GUIDE CATHETER LSD
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 618900 | RESOLUTE INTEGRITY RX | STENT, CORONARY, DRUG-ELUTING | NIQ | MEDTRONIC IRELAND |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 62 YR |